Neffy®(肾上腺素鼻喷雾剂)在华获批,成为首个且唯一可用于社区治疗的过敏反应(严重过敏)急救产品

美股速递
Dec 29, 2025

肾上腺素鼻喷雾剂Neffy®已正式获得中国监管部门的批准,该产品是首个且目前唯一获批用于社区场景、治疗过敏反应(严重过敏)的肾上腺素制剂。这一批准为患者提供了更为便捷和及时的治疗选择。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10